Chronobiological Analysis of Blood Pressure in a Patient with Atrial Fibrillation at the Development of Heart Failure and Its Therapeutic and Surgical Treatment

Table 1

Dynamics of the systolic blood pressure in 2010 in the patient GSK.

Stage	Time; (calendar dates in 2010)	MESOR	24-hour component			12-hour component
			Amplitude	Acrophase	𝑃 value	Amplitude	Acrophase	𝑃 value
1-2	05/01–19/01	117.5±4.4	14.5±3.2	−241±24	<0.0000	2.08±1.7	−219±200	0.5813
1-2	12/02–26/02	121.8±5.4	19.8±2.0	−226±13	<0.0000	2.02±1.7	−256±154	0.6531
1-2	02/04–16/04	115.9±3.7	15.4±5.2	−208±17	<0.0000	4.2±3.9	−259±115	0.2892
2-3	18/04–25/04	111.4±6.2	14.8±3.3	−226±16	<0.0000	5.9±2.9	−223±31	0.0600
3-4	26/04–04/05	109.8±4.8	11.8±3.2	−215±24	<0.0000	3.9±3.1	−254±37	0.1798
4-5	05/05–13/05	126.7±8.8	16.6±3.4	−222±34	<0.0000	6.5±6.2	−233±19	0.0934
5-6	14/05–18/05	127.4±7.4	5.1±6.8	−237±57	0.2261	11.3±1.6	−209±29	<0.0000
6-7	19/05–23/05	144 ± 6.1	7.2±4.1	−240±31	0.0529	7.2±6.2	−225±33	0.0415
7-8	24/05–26/05	136.1±9.3	13.0±5.2	−213±16	<0.0000	10.1±6.1	−226±25	0.0187
8	27/05	129.4±0.4	16.9±0.4	−216±1	<0.0000	5.9±0.3	−191±13	0.0424
8-9	28/05–30/05	124.3±5.0	14.8±3.9	−231±13	<0.0000	7.8±1.9	−179±20	0.0038
9	31/05	131.4±4.9	12.7±5.9	−210±15	0.0001	5.6±2.7	−180±31	0.0754
9-10	01/06-02/06	136.2±4.3	12.0±7.2	−213±18	0.0001	7.3±5.0	−220±33	0.0211
10-11	03/06–08/06	129.6 ± 9.8	6.5 ± 7.2	−216 15	<0.0000	12.5 ± 6.6	−201 ± 17	0.0035
11-12	09/06–17/06	122.9 ± 3.1	12.4 ± 3.3	−216 25	0.0005	12.5 ± 2.3	−204 ± 20	0.0004

Comments
Stages of developing process:
(1) out of disease (before April 18),
(2) beginning of acute respiratory illness (April 18),
(3) ankle oedema joints (April 26),
(4) dyspnoea joints (May 5),
(5) admission to the therapeutic clinic (May 14),
(6) copping heart failure (May 19),
(7) transferring to the surgical clinic (May 24),
(8) pacemaker transplanted (May 27),
(9) atrio-ventricular ablation performed (May 31),
(10) discharge (June 2),
(11) weekly rehabilitation at home (up to June 9),
(12) stabile state at home (after June 9).
After symbol “±” 95% confidence limits of values are shown.
Patient GSK, a man of 84.